SCHEMBL573711

SCHEMBL573711

CCC(c1ccccc1)c1c(O)cccc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.49
LMNA P02545 4/20 0.48
HKDC1 Q2TB90 1/20 0.47
TSHR P16473 3/20 0.45
HDAC4 P56524 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
HTR2A P28223 2/20 0.43
HRH1 P35367 2/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
BCHE P06276 1/20 0.42
TYR P14679 1/20 0.42
ACHE P22303 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29233063 0.90 TSHR (0.50) CYP2C9LMNAHKDC1TSHRHDAC4
SCHEMBL19433091 0.84 HKDC1 (0.49) CYP2C9LMNAHKDC1TSHRHDAC4
SCHEMBL16528760 0.84 AOC3 (0.43) LMNAHKDC1TSHRHDAC4HDAC2
SCHEMBL9269923 0.82 CYP2C9 (0.45) CYP2C9LMNAHKDC1TSHRHSD17B10
SCHEMBL27898104 0.82 EP300 (0.41) CYP2C9LMNAHKDC1KDM4EPOLB
SCHEMBL27661251 0.82 BCHE (0.61) CYP2C9LMNAHKDC1TSHRHDAC4
SCHEMBL1238318 0.81 TSHR (0.63) CYP2C9LMNAHKDC1TSHRHDAC4
SCHEMBL16528244 0.80 SIGMAR1 (0.46) ALDH1A1HTR2AHRH1
SCHEMBL28263630 0.80 BCHE (0.48) CYP2C9LMNATSHRHDAC4HDAC2
SCHEMBL31545182 0.79 TRPA1 (0.53) CYP2C9TSHRHDAC4HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 605 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12053537-B2 Reduction of stinging sensation on skin SYMRISE AG (DE) 2024-08-06 US claimed
CN-108472220-B Reducing the perception of skin stinging 西姆莱斯股份公司 2022-06-17 CN claimed
EP-3373895-B1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2020-08-19 EP claimed
CN-104414869-B A kind of skin and/or hair whitening mixture 西姆莱斯股份公司 2019-09-03 CN claimed
EP-3373895-A1 REDUCTION OF STINGING SENSATION ON SKIN Symrise AG (DE) 2018-09-19 EP claimed
CN-108472220-A Reduce skin irritation impression 西姆莱斯股份公司 2018-08-31 CN claimed
EP-2842607-B1 A skin and/or hair whitening mixture SYMRISE AG (DE) 2018-05-30 EP claimed
WO-2017080625-A1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2017-05-18 WO claimed
CN-104414869-A SKIN AND/OR HAIR WHITENING MIXTURE SYMRISE AG 2015-03-18 CN claimed
US-20150064122-A1 SKIN AND/OR HAIR WHITENING MIXTURE SYMRISE AG (DE) 2015-03-05 US claimed
EP-1879457-A1 ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES Ciba Specialty Chemicals Holding, Inc. (CH) 2008-01-23 EP claimed
US-20070231295-A1 Antimicrobial Silicon Oxide Flakes CIBA SPECIALTY CHEMICALS CORP. 2007-10-04 US claimed
EP-1755381-A2 ANTIMICROBIAL SILICON OXIDE FLAKES CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-02-28 EP claimed
WO-2006120135-A1 ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-11-16 WO claimed
US-20060040847-A1 Hard surface treating compositions RECKITT BENCKISER INC. 2006-02-23 US claimed
WO-2005107456-A2 ANTIMICROBIAL SILICON OXIDE FLAKES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-11-17 WO claimed
EP-1537201-A1 HARD SURFACE TREATING COMPOSITIONS Reckitt Benckiser Inc. (US) 2005-06-08 EP claimed
EP-0805672-B1 METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH HOMOLA ANDREW M (US) 2004-08-25 EP claimed
WO-2004024861-A1 HARD SURFACE TREATING COMPOSITIONS RECKITT BENCKISER INC (US) 2004-03-25 WO claimed
US-5665333-A Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth PROVSEAL LLC 1997-09-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12053537-B2 Reduction of stinging sensation on skin STING1, TYR, CUTA CYP2C9 4350/4885LMNA 3940/4885HKDC1 4412/4885
US-20150064122-A1 SKIN AND/OR HAIR WHITENING MIXTURE TYR, AHR, CYP1B1 CYP2C9 178/4885LMNA 325/4885HKDC1 2222/4885
US-20070231295-A1 Antimicrobial Silicon Oxide Flakes SIK2, SIK3, SIK1 CYP2C9 2461/4885LMNA 4300/4885HKDC1 3311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.